The Evan Bray Show - Matthew Kaeberlein - October 15th, 2024

Loading player...
A drug typically prescribed to suppress the immune systems of organ transplant patients is being used by everyday people, now, with the hope of delaying aging and age-related diseases. Dr. Matthew Kaeberlein, CEO of Optispan, an American healthcare technology company, joins Evan to discuss the hype around rapamycin.
15 Oct 2024 1PM English South Africa News Commentary

Other recent episodes

Spring melt season, is your home ready?

With spring right around the corner and warm weather in the forecast the spring melt is on across Saskatchewan! Jim Mandeville, disaster specialist, SVP at First Onsite Property Restoration, joins us to explain what you can do this weekend to keep your home and business safe from the risk of…
20 Mar 1PM 9 min